Febuxostat: A Selective Xanthine-Oxidase/Xanthine-Dehydrogenase Inhibitor for the Management of Hyperuricemia in Adults With Gout
- Autor
- ERNST, Michael E1 2 ; FRAVEL, Michelle A1
[1] Department of Pharmacy Practice and Science, College of Pharmacy, University of Iowa, Iowa City, Iowa, United States
[2] Department of Family Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, United States - Fuente
Clinical therapeutics. 2009, Vol 31, Num 11, pp 2503-2518, 16 p ; ref : 44 ref
- ISSN
- 0149-2918
- Campo Científico
- Pharmacology drugs
- Editor
- Elsevier, Bridgewater, NJ
- País de la publicación
- United States
- Tipo de documento
- Article
- Idioma
- English
- Palabra clave de autor
- allopurinol febuxostat gout hyperuricemia serum urate xanthine oxidase inhibitor
- Palabra clave (fr)
- Acide urique Adulte Allopurinol Conduite à tenir Fébuxostat Goutte (pathologie) Hyperuricémie Hypouricémiant Liquide biologique Microcristal Purine Sérum Xanthine dehydrogenase Xanthine oxidase Arthropathie microcristalline Enzyme Homme Inhibiteur enzyme Maladie métabolique Oxidoreductases Pathologie du système ostéoarticulaire Pyrazolopyrimidine dérivé
- Palabra clave (in)
- Uric acid Adult Allopurinol Clinical management Febuxostat Gout Hyperuricemia Hypouricemic agent Biological fluid Microcrystal Purine Serum Xanthine dehydrogenase Xanthine oxidase Microcristalline arthropathy Enzyme Human Enzyme inhibitor Metabolic diseases Oxidoreductases Diseases of the osteoarticular system Pyrazolopyrimidine derivatives
- Palabra clave (es)
- Urico ácido Adulto Alopurinol Actitud médica Febuxostat Gota (patología) Hiperuricemia Hipouricemiante Líquido biológico Microcristal Purina Suero Xanthine dehydrogenase Xanthine oxidase Artropatía por microcristales Enzima Hombre Inhibidor enzima Metabolismo patología Oxidoreductases Sistema osteoarticular patología Pyrazolopirimidina derivado
- Clasificación
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B15 Diseases of the osteoarticular system / 002B15D Inflammatory joint diseases
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B15 Diseases of the osteoarticular system / 002B15I Miscellaneous. Osteoarticular involvement in other diseases
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B22 Metabolic diseases / 002B22E Other metabolic disorders / 002B22E01 Purines and pyrimidines (gout, hyperuricemia...)
- Disciplina
- General pharmacology Metabolic diseases Osteoarticular pathology
- Procedencia
- Inist-CNRS
- Base de datos
- PASCAL
- Identificador INIST
- 22280227
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Acceso al documento
Install on your browser
DOI
10.1016/j.clinthera.2009.11.033 
https://dx.doi.org/10.1016/j.clinthera.2009.11.033
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2009.11.033\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:129:\"Febuxostat: A Selective Xanthine-Oxidase\/Xanthine-Dehydrogenase Inhibitor for the Management of Hyperuricemia in Adults With Gout\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Clinical therapeutics\";s:9:\"\u0000*\u0000stitle\";s:10:\"Clin. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"2503\";s:8:\"\u0000*\u0000epage\";s:4:\"2518\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-2918\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ERNST\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:18:\"FRAVEL, Michelle A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:129:\"Febuxostat: A Selective Xanthine-Oxidase\/Xanthine-Dehydrogenase Inhibitor for the Management of Hyperuricemia in Adults With Gout\";s:8:\"\u0000*\u0000place\";s:15:\"Bridgewater, NJ\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"16\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Acceso mediante Panist
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2009.11.033\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:129:\"Febuxostat: A Selective Xanthine-Oxidase\/Xanthine-Dehydrogenase Inhibitor for the Management of Hyperuricemia in Adults With Gout\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Clinical therapeutics\";s:9:\"\u0000*\u0000stitle\";s:10:\"Clin. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"2503\";s:8:\"\u0000*\u0000epage\";s:4:\"2518\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-2918\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ERNST\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:18:\"FRAVEL, Michelle A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:129:\"Febuxostat: A Selective Xanthine-Oxidase\/Xanthine-Dehydrogenase Inhibitor for the Management of Hyperuricemia in Adults With Gout\";s:8:\"\u0000*\u0000place\";s:15:\"Bridgewater, NJ\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"16\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Acceso mediante Istex
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2009.11.033\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Acceso mediante Unpaywall
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2009.11.033\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:129:\"Febuxostat: A Selective Xanthine-Oxidase\/Xanthine-Dehydrogenase Inhibitor for the Management of Hyperuricemia in Adults With Gout\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Clinical therapeutics\";s:9:\"\u0000*\u0000stitle\";s:10:\"Clin. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"2503\";s:8:\"\u0000*\u0000epage\";s:4:\"2518\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-2918\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ERNST\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:18:\"FRAVEL, Michelle A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:129:\"Febuxostat: A Selective Xanthine-Oxidase\/Xanthine-Dehydrogenase Inhibitor for the Management of Hyperuricemia in Adults With Gout\";s:8:\"\u0000*\u0000place\";s:15:\"Bridgewater, NJ\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"16\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Acceso mediante Europe PubMed Central
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.clinthera.2009.11.033\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:129:\"Febuxostat: A Selective Xanthine-Oxidase\/Xanthine-Dehydrogenase Inhibitor for the Management of Hyperuricemia in Adults With Gout\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Clinical therapeutics\";s:9:\"\u0000*\u0000stitle\";s:10:\"Clin. ther\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"31\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"2503\";s:8:\"\u0000*\u0000epage\";s:4:\"2518\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0149-2918\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"ERNST\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:18:\"FRAVEL, Michelle A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:129:\"Febuxostat: A Selective Xanthine-Oxidase\/Xanthine-Dehydrogenase Inhibitor for the Management of Hyperuricemia in Adults With Gout\";s:8:\"\u0000*\u0000place\";s:15:\"Bridgewater, NJ\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"16\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Acceso mediante arXiv
